av/transgene--big.svg

FR:TRANSGENE

Transgene

  • Stock

EUR

Last Close

0.79

25/11 09:00

Market Cap

106.75M

Beta: -

Volume Today

9.38K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '21
Jun '21
Sep '21
Dec '21
Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Jun '24
revenue
2.49M
-
1.36M
45.44%
6.13M
350.04%
8.63M
40.93%
3.04M
64.74%
2.30M
24.49%
2.07M
9.83%
828K
60.04%
2.38M
187.62%
1.16M
51.46%
1.57M
35.68%
28K
98.21%
23K
17.86%
cost of revenue
7.67M
-
7.67M
0%
8.77M
14.38%
8.77M
0%
8.49M
3.25%
8.49M
0%
7.60M
10.49%
7.60M
0%
7.78M
2.47%
7.78M
0%
7.01M
9.96%
gross profit
-5.17M
-
-6.31M
21.90%
-2.65M
58.04%
-140K
94.71%
-5.44M
3,788.21%
-6.19M
13.70%
-5.53M
10.73%
-6.77M
22.52%
-5.40M
20.18%
-6.63M
22.68%
-5.44M
17.92%
28K
100.51%
23K
17.86%
selling and marketing expenses
1.51M
-
1.43M
-
1.94M
-
1.95M
-
1.60M
-
general and administrative expenses
1.54M
-
1.54M
0%
2.14M
39.25%
2.14M
0%
1.97M
8.04%
1.97M
0%
1.98M
0.61%
1.98M
0%
1.63M
18.07%
1.63M
0%
1.87M
14.92%
selling general and administrative expenses
1.54M
-
3.05M
98.05%
2.14M
29.69%
3.58M
66.71%
1.97M
44.84%
3.91M
98.43%
1.98M
49.30%
3.94M
98.44%
1.63M
58.71%
3.22M
98.22%
1.87M
42.02%
3.67M
96.20%
4.54M
23.90%
research and development expenses
7.67M
-
14.46M
88.51%
8.77M
39.33%
16.66M
89.92%
8.49M
49.06%
16.17M
90.54%
7.60M
53.02%
14.39M
89.36%
7.78M
45.89%
14.79M
90.06%
7.01M
52.62%
13.29M
89.64%
14.83M
11.59%
other expenses
129K
-
cost and expenses
8.25M
-
18.42M
123.34%
10.31M
44.04%
21.83M
111.82%
10.69M
51.03%
20.92M
95.63%
12.00M
42.62%
19.16M
59.64%
10.05M
47.56%
18.82M
87.30%
8.54M
54.64%
16.96M
98.66%
19.85M
17.07%
operating expenses
577.50K
-
17.51M
2,931.69%
1.54M
91.23%
20.23M
1,217.81%
2.21M
89.10%
20.08M
810.63%
4.41M
78.06%
18.32M
315.82%
2.26M
87.65%
18.02M
695.98%
1.53M
91.53%
16.96M
1,010.91%
19.25M
13.49%
interest expense
86K
-
39K
-
542K
-
ebitda
-6.26M
-
-16.15M
158.06%
-4.36M
72.97%
-11.60M
165.88%
-7.00M
39.70%
-17.79M
154.19%
-6.92M
61.11%
-17.50M
152.93%
-7.25M
58.59%
-16.86M
132.73%
-6.75M
59.97%
-16.16M
139.40%
-18.54M
14.77%
operating income
-6.72M
-
-17.06M
153.99%
-5.13M
69.92%
-13.20M
157.25%
-7.42M
43.81%
-18.62M
151.03%
-7.59M
59.25%
-18.33M
141.62%
-7.67M
58.18%
-17.66M
130.41%
-7.36M
58.35%
-16.93M
130.12%
-19.83M
17.12%
depreciation and amortization
459K
-
911K
98.47%
767.50K
15.75%
1.60M
108.21%
420.50K
73.69%
834K
98.34%
671K
19.54%
839K
25.04%
421.50K
49.76%
803K
90.51%
607.50K
24.35%
772K
27.08%
606K
21.50%
total other income expenses net
816K
-
1.76M
115.93%
1.26M
28.29%
1.97M
56.23%
-222K
111.25%
-333K
50%
-1.17M
252.70%
-2.35M
100.09%
-284.50K
87.89%
-1.70M
498.59%
4.14M
343.34%
7.52M
81.44%
137K
98.18%
income before tax
-5.90M
-
-15.30M
159.25%
-3.87M
74.71%
-11.23M
190.25%
-7.64M
31.95%
-18.95M
148.09%
-8.76M
53.77%
-20.68M
136.05%
-7.95M
61.56%
-19.37M
143.58%
-3.21M
83.41%
-9.41M
192.90%
-19.69M
109.24%
income tax expense
-3.50M
-
-3.49M
-
-3.67M
-
-3.16M
-
-3.46M
-
-2.98M
-
-3.21M
7.44%
net income
-5.90M
-
-11.80M
100%
-3.87M
67.22%
-7.74M
100%
-7.64M
1.25%
-15.28M
100%
-8.76M
42.65%
-17.52M
100%
-7.95M
54.63%
-15.90M
100%
-3.21M
79.79%
-6.43M
100%
-16.48M
156.54%
weighted average shs out
84.29M
-
84.31M
0.02%
97.92M
16.15%
97.59M
0.33%
98.80M
1.24%
98.80M
0.00%
97.48M
1.34%
100.12M
2.71%
99.80M
-
103.19M
3.40%
100.96M
-
weighted average shs out dil
84.31M
-
84.31M
0%
97.92M
16.15%
97.59M
0.33%
98.80M
1.23%
98.80M
0%
100.20M
1.42%
100.12M
0.08%
99.80M
-
103.19M
3.40%
100.96M
-
eps
-0.07
-
-0.14
100%
-0.04
71.79%
-0.08
100.76%
-0.08
2.52%
-0.15
94.05%
-0.09
40.07%
-0.18
100.22%
0
100%
-0.16
Infinity%
-0.03
80.56%
-0.06
95.18%
-0.16
163.59%
epsdiluted
-0.07
-
-0.14
100%
-0.04
71.79%
-0.08
100.76%
-0.08
2.52%
-0.15
94.05%
-0.09
41.73%
-0.18
105.95%
0
100%
-0.16
Infinity%
-0.03
80.56%
-0.06
95.18%
-0.16
163.59%

All numbers in EUR (except ratios and percentages)